Q2 2013 Holdings
Filed 2013-08-14 | 75 holdings | $456.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $362.2M | 19,955,126 | 79.3% |
| Biomarin Pharmaceuticals(BMRN) | COM | 09061G101 | $43.7M | 783,311 | 9.6% |
| Cerus(CERS) | COM | 157085101 | $37.4M | 8,455,306 | 8.2% |
| Biocryst Pharmaceuticals Inc.(BCRX) | COM | 09058V103 | $8.6M | 5,563,615 | 1.9% |
| Pharmacyclics Inc. | COM | 716933106 | $856.0K | 10,771,138 | 0.2% |
| Seattle Genetics Inc. | COM | 812578102 | $607.9K | 19,322,947 | 0.1% |
| Genomic Health Inc.(GHDX) | COM | 37244C101 | $432.9K | 13,650,835 | 0.1% |
| Incyte Genomics Notes 4.75% 10/1/2015 | CONV BONDS | 45337CAH5 | $401.7K | $157,758,000 | 0.1% |
| Synageva Biopharma Corp. | COM | 87159A103 | $387.2K | 9,223,182 | 0.1% |
| Salix 2.75% 5/15/15 | CONV BONDS | 795435AC0 | $334.0K | $219,440,000 | 0.1% |
| Incyte Corp.(INCY) | COM | 45337C102 | $325.8K | 14,810,559 | 0.1% |
| Viropharma Inc. | COM | 928241108 | $244.3K | 8,528,603 | 0.1% |
| Auxilium 1.5% 7/15/2018 | CONV BONDS | 05334DAA5 | $88.1K | $91,590,000 | 0.0% |
| Xoma Corp. | COM | 98419J107 | $73.6K | 20,274,581 | 0.0% |
| Gilead Sciences Inc.(GILD) | COM | 375558103 | $63.9K | 1,245,800 | 0.0% |
| Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | $63.2K | $22,898,000 | 0.0% |
| Aegerion Pharmaceuticals | COM | 00767E102 | $58.5K | 924,343 | 0.0% |
| Halozyme Therapeutics Inc.(HALO) | COM | 40637H109 | $52.1K | 6,553,150 | 0.0% |
| Repros Therapeutics | COM | 76028H209 | $51.3K | 2,778,654 | 0.0% |
| Medivation 2.625% 4/1/17 | CONV BONDS | 58501NAA9 | $50.1K | $39,500,000 | 0.0% |
| Gilead 1.625% 5/1/16 | CONV BONDS | 375558AP8 | $48.7K | $21,500,000 | 0.0% |
| Intermune Inc Notes 2.5% 12/15/17 | CONV BONDS | 45884XAF0 | $43.9K | $41,000,000 | 0.0% |
| Clovis Oncology(CLVSEUR) | COM | 189464100 | $35.2K | 525,113 | 0.0% |
| Vanda Pharmaceuticals, Inc.(VNDA) | COM | 921659108 | $32.0K | 3,966,179 | 0.0% |
| Ariad Pharmaceuticals Inc. | COM | 04033A100 | $25.4K | 1,450,000 | 0.0% |
| Stemline Therapeutics Inc. | COM | 85858C107 | $21.5K | 900,000 | 0.0% |
| Intercept Pharmaceuticals, Inc.(ICPTUSD) | COM | 45845P108 | $20.8K | 462,847 | 0.0% |
| Medivation Inc. | COM | 58501N101 | $19.6K | 398,331 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $18.7K | 4,200,000 | 0.0% |
| Derma Sciences | COM | 249827502 | $18.1K | 1,358,857 | 0.0% |
| Intermune Inc Notes 5% 3/1/15 | CONV BONDS | 45884XAD5 | $17.8K | $16,860,000 | 0.0% |
| Avanir Pharmaceuticals | COM | 05348P401 | $16.5K | 3,578,591 | 0.0% |
| Infinity Pharmaceuticals Inc.(INFIQ) | COM | 45665G303 | $16.5K | 1,016,433 | 0.0% |
| Questcor Pharmaceuticals, Inc. | COM | 74835Y101 | $14.4K | 315,846 | 0.0% |
| Synergy Pharmaceuticals | COM | 871639308 | $11.3K | 2,608,271 | 0.0% |
| Chelsea Therapeutics | COM | 163428105 | $11.0K | 4,775,787 | 0.0% |
| Portola Pharmaceuticals, Inc. | COM | 737010108 | $9.8K | 399,914 | 0.0% |
| Insmed Inc.(INSM) | COM | 457669307 | $9.5K | 795,803 | 0.0% |
| Ironwood Pharmaceuticals(IRWD) | COM | 46333X108 | $9.2K | 922,160 | 0.0% |
| Threshold Pharma | COM | 885807107 | $8.4K | 1,595,048 | 0.0% |
| Synta Pharmaceuticals | COM | 87162T206 | $7.0K | 1,399,040 | 0.0% |
| Array Biopharma Inc.(ARRYEUR) | COM | 04269X105 | $6.8K | 1,500,000 | 0.0% |
| QLT, Inc. | COM | 746927102 | $6.7K | 1,535,863 | 0.0% |
| Isis Pharmaceuticals | COM | 464330109 | $6.6K | 247,036 | 0.0% |
| Chemocentryx Inc.(CCXIEUR) | COM | 16383L106 | $5.3K | 375,000 | 0.0% |
| Ambit Biosciences Corp. | COM | 02318X100 | $5.2K | 747,962 | 0.0% |
| Xenoport | COM | 98411C100 | $5.1K | 1,034,112 | 0.0% |
| Anacor Pharmaceuticals | COM | 32420101 | $4.9K | 876,463 | 0.0% |
| Prothena Corp. PLC(PRTA) | COM | G72800108 | $4.8K | 369,650 | 0.0% |
| Kythera Biopharmaceuticals | COM | 501570105 | $4.5K | 165,000 | 0.0% |